Predicting drug resistance

Predicting drug resistance

A new approach helps examine the proportion of cancerous and healthy stem cells in patients with chronic myeloid leukemia and how this influences treatment outcomes.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:eLife 2024-11, Vol.13
Hauptverfasser: Arellano, Nicole S, Elf, Shannon E
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Bone marrow
Cancer
Cancer Biology
Cancer therapies
CD26
CD35
Chronic myeloid leukemia
CITE-Seq
Clinical outcomes
CML
Drug resistance
Drug Resistance, Neoplasm
Genetics and Genomics
Humans
Insight
Kinases
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics
leukemic stem cell
Mutation
Myeloid leukemia
Neoplastic Stem Cells - drug effects
Patients
Proteins
Stem cells
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A new approach helps examine the proportion of cancerous and healthy stem cells in patients with chronic myeloid leukemia and how this influences treatment outcomes.
ISSN:2050-084X
2050-084X
DOI:10.7554/eLife.103775